FULC
Fulcrum Therapeutics, Inc.Company with tickers: FULC
CIK
1680581
CUSIP
359616109
Shares Outstanding
66,633,321
13F Activity (30d)
110 filings
106 filers
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2025-12-15 | CURTIS G OLTMANS | Officer | 3,452 | 2025-12-15 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-12-08 | RA Capital Healthcare Fund LP | 10% Stockholder | 4,175,139 | 2025-12-08 | BTIG, LLC |
| 2025-11-19 | ROBERT J GOULD | Director | 45,000 | 2025-11-19 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2024-03-08 | Greg Tourangeau | Officer | 4,884 | 2024-03-08 | Merrill Lynch, Pierce, Fenner & Smith Inc |
Showing 1–4 of 4 filings